Skip to content

Comparison of two artificial pancreas systems for closed-loop blood glucose control versus open loop control in patients with Type 1 diabetes

Comparison of two artificial pancreas systems for closed-loop blood glucose control versus open loop control in patients with Type 1 diabetes - CAT trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON34528
Enrollment
8
Registered
2010-09-17
Start date
2010-10-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

The intervention consists of the regulation of plasma glucose by means of the artificial pancreas. The three treatment arms are: 1. closed loop with the algorithm from Cambridge 2. closed loop with

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: aged 18 years or above diagnosed with Type 1 diabetes mellitus at least 6 months according to the WHO definition Body Mass Index (BMI)

Exclusion criteria

Exclusion criteria: Patient is pregnant, or breast feeding during the period of the study Symptomatic coronary artery disease Patient is using a medication that significantly impacts glucose metabolism

Design outcomes

Primary

MeasureTime frame
Time spent in target range; this is defined as plasma glucose values between 3.9 and 8.0 mmol/L in the basal or late postprandial state (more than 3 hours after breakfast, lunch and dinner) and plasma glucose values between 3.9 and 10.0 mmol/L in the early postprandial state (first 3 hours after breakfast, lunch and dinner).

Secondary

MeasureTime frame
* Time spent in hypoglycaemia defined as plasma glucose value 8 mmol/l in the basal or late postprandial state and >10 mmol/l in the early postprandial state * Mean and standard deviation of plasma glucose * Time spent in target range defined as CGM glucose values between 3.9 and 8.0 mmol/L in the basal or late postprandial state and CGM glucose values between 3.9 and 10.0 mmol/L in the early postprandial state * Time spent in hypoglycaemia defined as CGM glucose value 8 mmol/l in the basal or late postprandial state and >10 mmol/l in the early postprandial state * Mean and standard deviation of CGM glucose values * Total number of insulin units infused * Median plasma insulin concentration * Total duration of treatment in minutes

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)